We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
-3.14%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$52.8B
AUM Growth
-$1.34B
Cap. Flow
+$1.39B
Cap. Flow %
2.62%
Top 10 Hldgs %
12%
Holding
4,607
New
780
Increased
956
Reduced
789
Closed
1,336

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$532M
2
WFC icon
Wells Fargo
WFC
+$480M
3
V icon
Visa
V
+$435M
4
VZ icon
Verizon
VZ
+$320M
5
AVGO icon
Broadcom
AVGO
+$273M

Sector Composition

Rank Sector Weight
1 Financials 18.66%
2 Technology 16.35%
3 Healthcare 16.13%
4 Consumer Discretionary 11.2%
5 Industrials 7.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CMCAW
1901
CALL
DELISTED
Capitalworks Emerging Markets Acquisition Corp Warrant
CMCAW
$2.48M ﹤0.01%
+249,999
New +$74.5K
PPYAW
1902
CALL
DELISTED
Papaya Growth Opportunity Corp. I Warrant
PPYAW
$2.48M ﹤0.01%
+249,999
New +$49.4K
ABPWW
1903
CALL
DELISTED
Abpro Holdings Warrant
ABPWW
$2.48M ﹤0.01%
+249,999
New +$44.9K
PJT icon
1904
PJT Partners
PJT
$4.34B
$2.48M ﹤0.01%
+39,286
New +$2.56M
BTMDW
1905
CALL
DELISTED
Biote Corp. Warrant
BTMDW
$2.47M ﹤0.01%
250,000
FRW
1906
DELISTED
PWP Forward Acquisition Corp. I Class A Common Stock
FRW
$2.47M ﹤0.01%
252,827
+23,592
+10% +$230K
TSIB
1907
DELISTED
Tishman Speyer Innovation Corp. II Class A common stock
TSIB
$2.46M ﹤0.01%
251,476
BETRW icon
1908
CALL
Better Home & Finance Warrant
BETRW
$2.55M
$2.46M ﹤0.01%
250,000
RDW.WS
1909
CALL
DELISTED
Redwire Corporation Redeemable Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share
RDW.WS
$2.46M ﹤0.01%
290,576
-9,424
-3% -$15.3K
RRGB icon
1910
Red Robin
RRGB
$143M
$2.46M ﹤0.01%
146,083
-36,995
-20% -$598K
FVIV.WS
1911
CALL
DELISTED
Fortress Value Acquisition Corp. IV Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share
FVIV.WS
$2.45M ﹤0.01%
249,994
CRZNW
1912
CALL
DELISTED
Corazon Capital V838 Monoceros Corp Warrant
CRZNW
$2.45M ﹤0.01%
249,996
GHACW
1913
CALL
DELISTED
Gaming & Hospitality Acquisition Corp. Warrants
GHACW
$2.44M ﹤0.01%
249,994
BSLKW
1914
CALL
DELISTED
Bolt Projects Holdings Warrant
BSLKW
$2.44M ﹤0.01%
249,997
LCAAW
1915
CALL
DELISTED
L Catterton Asia Acquisition Corp Warrant
LCAAW
$2.44M ﹤0.01%
249,996
GGMCW
1916
CALL
DELISTED
Glenfarne Merger Corp. Warrant
GGMCW
$2.44M ﹤0.01%
249,996
AFAQW
1917
CALL
DELISTED
AF Acquisition Corp Warrants
AFAQW
$2.44M ﹤0.01%
249,997
PV.WS
1918
CALL
DELISTED
Primavera Capital Acquisition Corporation Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
PV.WS
$2.44M ﹤0.01%
247,610
+29,069
+13% +$10.9K
GCMGW
1919
CALL
DELISTED
GCM Grosvenor Inc Warrant
GCMGW
$2.43M ﹤0.01%
250,000
THC icon
1920
Tenet Healthcare
THC
$22.3B
$2.41M ﹤0.01%
28,053
-192,722
-87% -$15.8M
NCACW
1921
CALL
DELISTED
Newcourt Acquisition Corp Warrant
NCACW
$2.41M ﹤0.01%
240,385
PPC icon
1922
Pilgrim's Pride
PPC
$7.08B
$2.41M ﹤0.01%
95,898
+63,773
+199% +$1.65M
ASTS icon
1923
AST SpaceMobile
ASTS
$17.1B
$2.4M ﹤0.01%
240,513
+98,277
+69% +$721K
ACIW icon
1924
ACI Worldwide
ACIW
$6.14B
$2.4M ﹤0.01%
+76,215
New +$2.54M
EMN icon
1925
Eastman Chemical
EMN
$7.71B
$2.4M ﹤0.01%
21,412
+21,391
+101,862% +$2.51M

Similar funds

Marshall Wace's Q1 2022 Portfolio in Review

As of Q1 2022, Marshall Wace held 4,607 positions worth $52.8B, down 2.5% from $54.2B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Marshall Wace's Q1 2022 filing shows 780 new, 956 increased, 789 reduced and 1,336 closed positions. Its largest new stake was Agilent Technologies: 1,082,487 shares worth $143M. The largest sale was Microsoft, an estimated $547M.

By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 16% a quarter earlier, followed by Technology and Healthcare.

  • Marshall Wace's largest Q1 2022 buy was Agilent Technologies: 1,082,487 shares worth $143M.
  • Marshall Wace added most to Merck in Q1 2022, an estimated $532M increase.
  • Marshall Wace's biggest Q1 2022 reduction was Microsoft, cutting an estimated $547M.
  • Marshall Wace fully exited Elevance Health in Q1 2022, selling an estimated $226M.
  • Marshall Wace's ten largest holdings make up 12% of its $52.8B portfolio in Q1 2022.
  • Marshall Wace opened 780 new positions and closed 1,336 in Q1 2022.
  • Marshall Wace's portfolio value fell 2.5% quarter-over-quarter to $52.8B.

Based on Marshall Wace's 13F filing for Q1 2022, filed 16 May 2022.